Department of Endocrinology, The Third People's Hospital of Datong, Datong, China.
Department of Medicine, Ashermed Pharmaceutical Technology Co Ltd, Shanghai, China.
BMJ Open. 2021 Nov 29;11(11):e053698. doi: 10.1136/bmjopen-2021-053698.
The prevalence of type 2 diabetes mellitus (T2DM) and hypertension (HTN) has notably increased in recent years. However, there is little evidence from large-scale studies assessing the joint effect of T2DM and HTN on the risk of cardiovascular events in China. This study was performed to investigate the association of T2DM and HTN with the incidence of combined vascular events (VEs) and stroke in China.
A retrospective cohort study.
Data were collected from the SuValue database which includes the electronic medical records of >90 million patients from 161 hospitals across 18 provinces in China.
Patients aged ≥18 with a diagnosis of T2DM and/or HTN were included. Non-T2DM and non-HTN patients were included in this study as controls.
Incidence of combined VEs and stroke during the study.
In the current study, 8012 patients with T2DM, 9653 patients with HTN, 3592 patients with both T2DM and HTN and 10 561 patients without T2DM or HTN were included. T2DM was significantly associated with combined VE and stroke risk (HR 1.332, 95% CI 1.134 to 1.565 and HR 1.584, 95% CI 1.246 to 2.014, respectively). HTN was significantly associated with combined VE and stroke risk (HR 3.244, 95% CI 2.946 to 3.572 and HR 4.543, 95% CI 3.918 to 5.268, respectively). T2DM combined with HTN was significantly associated with combined VE and stroke risk (HR 3.002, 95% CI 2.577 to 3.497 and HR 4.151, 95% CI 3.346 to 5.149, respectively). HTN was associated with a higher combined VE and stroke risk than T2DM (HR 2.435, 95% CI 2.113 to 2.805 and HR 2.868, 95% CI 2.341 to 3.513, respectively).
T2DM and HTN were strongly associated with combined VE and stroke risk; however, the HTN-only group had a higher combined VE and stroke risk than the T2DM-only group.
近年来,2 型糖尿病(T2DM)和高血压(HTN)的患病率显著增加。然而,很少有大规模研究评估 T2DM 和 HTN 联合对中国心血管事件风险的影响。本研究旨在探讨 T2DM 和 HTN 与中国联合血管事件(VE)和卒中发生率的关系。
回顾性队列研究。
数据来自 SuValue 数据库,该数据库包含来自中国 18 个省份 161 家医院的超过 9000 万患者的电子病历。
年龄≥18 岁,诊断为 T2DM 和/或 HTN 的患者。非 T2DM 和非 HTN 患者被纳入本研究作为对照组。
研究期间联合 VE 和卒中的发生率。
本研究共纳入 8012 例 T2DM 患者、9653 例 HTN 患者、3592 例 T2DM 和 HTN 并存患者和 10561 例无 T2DM 或 HTN 患者。T2DM 与联合 VE 和卒中风险显著相关(HR 1.332,95%CI 1.134 至 1.565 和 HR 1.584,95%CI 1.246 至 2.014)。HTN 与联合 VE 和卒中风险显著相关(HR 3.244,95%CI 2.946 至 3.572 和 HR 4.543,95%CI 3.918 至 5.268)。T2DM 合并 HTN 与联合 VE 和卒中风险显著相关(HR 3.002,95%CI 2.577 至 3.497 和 HR 4.151,95%CI 3.346 至 5.149)。HTN 与联合 VE 和卒中风险相关高于 T2DM(HR 2.435,95%CI 2.113 至 2.805 和 HR 2.868,95%CI 2.341 至 3.513)。
T2DM 和 HTN 与联合 VE 和卒中风险密切相关;然而,HTN 组的联合 VE 和卒中风险高于 T2DM 组。